van Kamp GJ - Search Results

1

Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.

van Kamp GJ, von Mensdorff-Pouilly S, Kenemans P, Verstraeten R, Yedema CA, Wobbes T, Bon GG, Kok A, Brown JP, Hilgers J, et al. van Kamp GJ, et al. Clin Chem. 1993 Jun;39(6):1029-32. Clin Chem. 1993. PMID: 8504532

2

Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas.

Yedema CA, Kenemans P, Wobbes T, Thomas CM, Bon GG, Mulder C, Voorhorst FJ, Verstraeten AA, van Kamp GJ, Hilgers J. Yedema CA, et al. Among authors: van kamp gj. Tumour Biol. 1992;13(1-2):18-26. doi: 10.1159/000217748. Tumour Biol. 1992. PMID: 1589694

3

Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125.

Kenemans P, Bon GG, Kessler AC, Verstraeten AA, van Kamp GJ. Kenemans P, et al. Among authors: van kamp gj. Clin Chem. 1992 Aug;38(8 Pt 1):1466-71. Clin Chem. 1992. PMID: 1643716

4

Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.

Yedema KA, Kenemans P, Wobbes T, van Kamp GJ, de Bruijn HW, Thomas CM, Massuger LF, Schijf CP, Bon GG, Vermorken JB, et al. Yedema KA, et al. Among authors: van kamp gj. Int J Cancer. 1991 Jan 21;47(2):170-9. doi: 10.1002/ijc.2910470203. Int J Cancer. 1991. PMID: 1988362

5

The second generation CA 125 assays.

Kenemans P, Verstraeten AA, van Kamp GJ, von Mensdorff-Pouilly S. Kenemans P, et al. Among authors: van kamp gj. Ann Med. 1995 Feb;27(1):107-13. doi: 10.3109/07853899509031945. Ann Med. 1995. PMID: 7741988 Free article.

6

Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.

Kenemans P, van Kamp GJ, Oehr P, Verstraeten RA. Kenemans P, et al. Among authors: van kamp gj. Clin Chem. 1993 Dec;39(12):2509-13. Clin Chem. 1993. PMID: 8252723

7

Discordant serum CA 125 values in commercial immunoassays.

van Kamp GJ, Verstraeten AA, Kenemans P. van Kamp GJ, et al. Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):99-103. doi: 10.1016/0028-2243(93)90132-v. Eur J Obstet Gynecol Reprod Biol. 1993. PMID: 8365530

8

CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery.

Yedema CA, Kenemans P, Thomas CM, Massuger LF, Wobbes T, Verstraeten R, van Kamp GJ, Hilgers J. Yedema CA, et al. Among authors: van kamp gj. Eur J Cancer. 1993;29A(7):966-71. doi: 10.1016/s0959-8049(05)80203-5. Eur J Cancer. 1993. PMID: 8499150

9

Multicenter evaluation of the Abbott IMx CA 15-3 assay.

van Kamp GJ, Bon GG, Verstraeten RA, Lynch D, Krikau M, Flückiger J, Ruibal A, Kenemans P. van Kamp GJ, et al. Clin Chem. 1996 Jan;42(1):28-33. Clin Chem. 1996. PMID: 8565228

10

Mucin-like carcinoma-associated antigen serum levels in patients with adenocarcinomas originating from ovary, breast and colon.

Bon GG, Verheijen RH, Zuetenhorst JM, van Kamp GJ, Verstraeten AA, Kenemans P. Bon GG, et al. Among authors: van kamp gj. Gynecol Obstet Invest. 1996;42(1):58-62. doi: 10.1159/000291890. Gynecol Obstet Invest. 1996. PMID: 8840180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters